The global proteomics market revenue was around US$ 23,654.3 million in 2022 and is estimated to reach US$ 97,372.1 million by 2031, growing at a compound annual growth rate (CAGR) of 15.2% during the forecast period from 2023 to 2031.
Proteomics is defined as the branch of biotechnology concerned with applying the techniques of molecular biochemistry, biology, and genetics. It analyzes the function, structure, and interactions of the proteins created by the genes of a particular tissue, cell, or organism by organizing the details in databases, and with applications of the data (as in biology and medicine).
Market Driving Factors
Technological advancements and surging R&D expenditure boost the market. Manufacturers in the proteomics industry are focusing on delivering new equipment and methods for disease diagnosis. This is expected to provide information on the rate of progression of cancer and other infectious disorders as well as the projected length of patient survival. Companies like Agilent Technologies Inc. have realized using technology out-licensing techniques to focus on the creation of protein analysis products.
The increase in technological advancements in the field of proteomics is estimated to propel the market growth. For instance, in June 2022, Bruker Corporation launched a unique product for the development of the revolutionary 4D multiomics timsTOF platform with the introduction of the new timsTOF HT system.
Proteomic technologies possess a high possibility in the search for new clinical biomarkers for earlier detection and diagnosis of cancer and other diseases as well and the discovery of new therapeutic targets from accessible bio-specimens creates a prospect for the proteomics market.
The high price associated with proteomics components such as reagents, instruments, and other products is expected to limit the market growth.
Regional Analysis
North America dominated the market and is estimated to retain its dominance during the projection period. This can be attributed to the presence of several major players, such as Bio-Rad Laboratories, Danaher Corporation, and Thermo Fisher Scientific, and advancement in manufacturing technology of proteomics. Additionally, the increase in investments in the development of structure-based drug design, the surge in growth in omics research, and the increase in the demand for high-quality research tools for data reproducibility surged the demand for proteomics in the region which boosted the market growth.
Asia-Pacific is estimated to increase at the highest rate in the market. This is due to the presence of pharmaceutical companies in the region as well as the increase in the geriatric population of the countries, such as India and China. Furthermore, the increase in demand for personalized medicine surges the demand for drug discovery, and advances in the biotechnology sector boost the market growth. In addition, this region exhibits the largest medicine supply and the pharmaceutical industry with the availability of raw materials and technologically cutting-edge medical devices in abundance which producers of proteomics-based products can easily access. This factor contributes to boosting the market growth.
Segmentation Insights
Component Insight
The reagent segment dominated the market and is estimated to maintain its dominance over the forecast period. This can be attributed that this segment is widely used in academic research facilities and research labs to analyze a variety of biological samples, which raises the demand for reagents. Therefore, this factor propels the segment's growth.
Application Insight
The drug discovery segment dominated the market. This is attributed to advances in proteomics have assisted researchers in formulating medicines that are personalized for various individuals to achieve better effectiveness and lower side effects.
Prominent Companies
Segmentation Outline
The global proteomics market segmentation focuses on Component, Application, and Region.
By Component
By Application
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL PROTEOMICS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: PROTEOMICS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL PROTEOMICS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL PROTEOMICS MARKET, BY COMPONENT
5.1 OVERVIEW
5.2 REAGENTS
5.2.1 MICROARRAY
5.2.2 X-RAY CRYSTALLOGRAPHY
5.2.3 SPECTROMETRY
5.2.4 CHROMATOGRAPHY
5.2.5 ELECTROPHORESIS
5.2.6 IMMUNOASSAY
5.2.7 PROTEIN FRACTIONATION REAGENTS
5.3 INSTRUMENTS
5.3.1 MICROARRAY
5.3.2 SPECTROMETRY
5.3.2.1 MASS SPECTROMETRY
5.3.2.2 NMR SPECTROMETRY
5.3.3 CHROMATOGRAPHY
5.3.3.1 HPLC CHROMATOGRAPHY
5.3.3.2 ION CHROMATOGRAPHY
5.3.3.3 AFFINITY CHROMATOGRAPHY
5.3.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
5.3.4 ELECTROPHORESIS
5.3.5 SURFACE PLASMON RESONANCE
5.3.6 X-RAY CRYSTALLOGRAPHY
5.3.7 PROTEIN FRACTIONATION REAGENTS
5.4 SERVICES
6 GLOBAL PROTEOMICS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DRUG DISCOVERY
6.3 DISEASE DIAGNOSIS
6.4 OTHERS
7 GLOBAL PROTEOMICS MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL PROTEOMICS MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 MERCK KGAA
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 PERKIN ELMER INC
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 THERMO FISHER SCIENTIFIC INC
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 AGILENT TECHNOLOGIES INC
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 BRUKER CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 DANAHER CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 WATERS CORPORATION
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 BIO-RAD LABORATORIES INC
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 LI-COR INC
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.10 HORIBA LTD
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved